Indian Pharmaceutical Exports Reach Nearly $29 Billion by February 2026
Indian Pharma sector clocks USD 29 bn export by end of February in FY26
News 18
Image: News 18
Indian pharmaceutical exports have reached approximately $29 billion by February 2026, marking a 5% growth compared to the previous year. The sector, currently valued at $60 billion, is expected to grow to $130 billion by 2030, driven by formulations, biologicals, and vaccines.
- 01Pharmaceutical exports reached nearly $29 billion by February 2026.
- 02The sector grew by 5% compared to the same period last year.
- 03Current market valuation is approximately $60 billion.
- 04Projected growth to $130 billion by 2030.
- 05Exports in FY 2024-25 reached $30.47 billion, a 9.4% year-on-year increase.
Advertisement
In-Article Ad
Indian pharmaceutical exports have achieved nearly $29 billion by February 2026, reflecting a 5% growth from the same timeframe last year. K Raja Bhanu, Director General of the Pharmaceuticals Export Promotion Council of India (PHARMEXCIL), highlighted that despite global challenges, the sector has shown resilience, with exports driven primarily by formulations, biologicals, vaccines, and Ayush products. The sector is currently valued at around $60 billion and is projected to expand to $130 billion by 2030. In FY 2024-25, pharmaceutical exports reached $30.47 billion, representing a 9.4% increase year-on-year, despite facing global pricing pressures and trade volatilities.
Advertisement
In-Article Ad
The growth in pharmaceutical exports indicates a robust demand for Indian medicines globally, which may lead to increased job opportunities in the sector and potential price stability for consumers.
Advertisement
In-Article Ad
Reader Poll
Do you believe the Indian pharmaceutical sector can achieve its $130 billion target by 2030?
Connecting to poll...
More about Pharmaceuticals Export Promotion Council of India
Read the original article
Visit the source for the complete story.